| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $400K | — | — |
| SG&A Expense | $701K | — | +165.3% |
| Operating Income | -$1.1M | — | — |
| Net Income | -$1.1M | — | — |
| EPS (Basic) | -$0.03 | — | +98.8% |
| EPS (Diluted) | -$0.03 | — | +98.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $2.8M | +455.1% | — |
| Total Assets | $2.8M | +444.1% | — |
| Current Liabilities | $2.9M | -71.9% | — |
| Total Liabilities | $2.9M | -71.7% | — |
| Stockholders' Equity | -$133K | +98.6% | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.0M | — | — |
| Investing Cash Flow | -$575K | — | +0.0% |
| Financing Cash Flow | $3.6M | — | +402.8% |